Choice plus study

Ended Definitive Contract Awarded Last action

Contract number
75N90023C00013
Awardee
Awarding agency
Obligated
$8,740,601

Award facts

Contract value 100% obligated
$8,740,601.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21201, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $8,740,601

About this award

This is a $8,740,601 definitive, firm fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to the University of Maryland, Baltimore. The contract is for the "CHOICE PLUS STUDY" to assess gaps in care for patients hospitalized with infectious complications from opioid use disorder and develop interventions to improve outcomes. The 2-year base period has 3 one-year option periods, and there is no set-aside designation. The University of Maryland, Baltimore is a state-controlled institution of higher learning that provides a wide range of medical research, clinical services, and educational support to federal agencies. Key subcontractors include Emory University, West Virginia University, George Washington University, and Friends Research Institute, all of which have extensive federal contract and grant experience in healthcare research.

Subawards

Subcontractor Amount Awarded
George Washington University (The) CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) -$184,211
Emory University CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use. -$180,348
Weill Medical College Of Cornell University CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE). $212,309
Emory University CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) $752,515
West Virginia University CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) $1,499,916
George Washington University (The) CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) $751,913
Friends Research Institute, Inc. CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) $119,806
Emory University CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) $752,515
George Washington University (The) CHOICE PLUS STUDY The Continuum of Care in Hospitalized Patients with Opioid Use Disorder and Infectious Complications of Drug Use (CHOICE) $748,760

Quick answers

Who was awarded contract 75N90023C00013?

75N90023C00013 was awarded to University Of Maryland, Baltimore by NIH Clinical Center (National Institutes of Health) on September 30, 2023.

How much is contract 75N90023C00013 worth?

The government has obligated $8,740,601 on 75N90023C00013.

Was contract 75N90023C00013 competed?

The extent of competition for 75N90023C00013 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award